With unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup...
With unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup and bringing change to entrenched silos that stall trial operations.
With unrelenting pressures to rein in budgets and cycle times, stakeholders are turning to quality as a solution, starting with building it into study startup and bringing change to entrenched silos...
The Association of Clinical Research Organizations (ACRO) provides the needed forum for leading CROs to collaborate and discuss this rapidly changing world of...
The Association of Clinical Research Organizations (ACRO) provides the needed forum for leading CROs to collaborate and discuss this rapidly changing world of technology, regulatory requirements /guidance and industry standards in clinical research.
The Association of Clinical Research Organizations (ACRO) provides the needed forum for leading CROs to collaborate and discuss this rapidly changing world of technology, regulatory...
The capture of big data and a technical ability to analyze it is frequently referred to as one of the top 10 clinical innovations in the last decade.
Unfortunately, most mass media coverage of clinical trials has been negative and/or unbalanced, focusing largely on risks, human error, and questionable...
Unfortunately, most mass media coverage of clinical trials has been negative and/or unbalanced, focusing largely on risks, human error, and questionable motives.
The hesitancy to change is understandable given the potential impact on an organization. Are decentralized and hybrid trials right for your organization?
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully,...
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully, providing both parties a compelling incentive to strengthen their partnership with the help of the right structure, tools, and strategies.
The future success of the life science industry in bringing new products to market rests on the ability of sponsors and CROs to work together successfully, providing both parties a...
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on...
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on organizational structure of clinical operations teams, but what do the industry metrics have to say about cycle time performance of multi-country vs. single country studies? And economies of scale in clinical trials?
Globalization is adding to the complexity of running clinical trials and the pursuit of global trials is increasing. Globalization has an obvious impact on organizational structure of clinical...
As the industry evolves and data types, structures, and volume continue to increase, technology must also evolve.
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that...
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that consider disease progression and early preventative measures.
As medical practitioners increasingly seek to provide proactive management for their patients health, new digitally enabled therapies are being developed that consider disease progression and early...
